• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    GENFIT S.A. - American Depositary Shares (NQ:GNFT)

    4.280 +0.370 (+9.46%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 9, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about GENFIT S.A. - American Depositary Shares

    < Previous 1 2 3 4 Next >
    12 Health Care Stocks Moving In Tuesday's Intraday Session
     
    Via Benzinga
    Earnings Scheduled For September 22, 2025
     
    Via Benzinga
    Dow Hits Record High As Fed Cuts Rates: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
    The CNN Money Fear and Greed index improved while remaining in the Greed zone on Friday. Dow and S&P 500 rose, Nasdaq surged. 
    Via Benzinga
    Topics Economy Stocks
    Globus Maritime, Firefly Aerospace And 3 Stocks To Watch Heading Into Monday
    U.S. stock futures down, Firefly Aerospace, PRA Group, Genfit, Globus Maritime, & Marygold Companies in focus. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
     
    Via Benzinga
    Earnings Scheduled For April 24, 2025
     
    Via Benzinga
    Analyst Expectations for Genfit's Future
     
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
     
    Via Benzinga
    Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2
     
    Via Benzinga
    Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    Baidu, XPeng And Other Big Stocks Moving Lower In Monday's Pre-Market Session
     
    Via Benzinga
    Top 4 Health Care Stocks That May Keep You Up At Night
     
    Via Benzinga
    Why Nike Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo
    The U.S. FDA has granted accelerated approval for Iqirvo, a novel drug from Ipsen SA and Genfit SA, designed for treating primary biliary cholangitis (PBC). This approval, based on the drug's ability... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
     
    Via Benzinga
    Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
     
    Via Benzinga
    Why Zscaler Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    Earnings Scheduled For April 4, 2024
    Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on revenue of $3.01 billion. 
    Via Benzinga
    Why CymaBay Morphed From Dollar Stock To Biotech Rocket
    The company is working on the first treatment that could make a difference in the itching associated with a liver disease. 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
     
    Via Benzinga
    Why CymaBay, With 172% Growth This Year, Just Surged For A Second Day Running
    The company is working on a treatment for a liver disease that can cause severe itching. 
    Via Investor's Business Daily
    Intercept Pharma Gets Double Upgrade: Analyst Says OCA Combo Therapy Can Extend PBC Business
    HC Wainwright has upgraded Intercept Pharmaceuticals Inc (NASDAQ: ICPT) to Buy from Sell, with a price target of  
    Via Benzinga
    Genfit's Miss Is CymaBay Therapeutics' Gain: Analyst Says Rival Data Leaves Room for Seladelpar To Emerge As Best-In-Class
    Friday, CymaBay Therapeutics Inc's (NASDAQ: CBAY) competitors Genfit SA (NASDAQ: GNFT) and Ipsen SA (OTC:  
    Via Benzinga
    Ipsen, Genfit's Elafibranor Shows Promise In Primary Biliary Cholangitis Patients
    Ipsen SA (OTC: IPSEY) and Genfit SA (NASDAQ: GNFT)  
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
     
    Via Benzinga
    Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket
    Gainers Renalytix Plc (NASDAQ: RNLX) shares surged 48.7% to $3.02 in pre-market trading after the company received FDA De Novo marketing authorization for its KidneyIntelX.dkd prognostic test. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    It's the final day of trading this week and we're starting off with a breakdown of the biggest pre-market stock movers worth watching today! 
    Via InvestorPlace
    Former Wall Street Darling Intercept Restructures After FDA Rejects Its Liver Drug
    Following the FDA rejection, Intercept will restructure to focus on rare liver diseases. 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
     
    Via Benzinga
    What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur
    On Friday, FDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that the benefits of Intercept Pharmaceutical Inc's ICPT Ocaliva 25 mg, also known as Obeticholic acid... 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.